Inhibition of tumor cell proliferation by linear polyunsaturated aldehydes

International Journal of Immunotherapy

Volumn 19, Issue 1, 2003, Pages 17-23

  Calastretti, A ^a   Bevilacqua, A ^a   Canti, G ^a   Testorelli, C ^a   Asnaghi, L ^a   Nicolin, Angelo ^a   Bertelli, A ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2,4,6 TRANSOCTATRIENALE; ALDEHYDE DERIVATIVE; ANTIOXIDANT; CAROTENOID; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; BREAST CELL; CANCER INHIBITION; CANCER PREVENTION; CELL CULTURE; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL SUSPENSION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG RESEARCH; DRUG STRUCTURE; DRUG SYNTHESIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYMPHOID CELL; MONOLAYER CULTURE; NEUROBLASTOMA CELL; STATISTICAL SIGNIFICANCE; TUMOR CELL;

EID: 0346656885     PISSN: 02559625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Gharib M.I., Burnett A.K. Chemotherapy-induced cardiotoxicity: Current practice and prospects of prophylaxis. Eur. J. Heart Fail., 4, 235, 2002.
2. Fraiser L.H., Kanekal S., Kehrer J.P. Cyclophosphamide toxicity. Characterising and avoiding the problem. Drugs, 42, 781, 1991.
3. Kintzel P.E. Anticancer drug-induced kidney disorders. Drug Safety, 24, 19, 2001.
4. Kinsella A.R., Smith D. Tumor resistance to anti-metabolites. Gen. Pharmacol., 30, 623, 1998.
5. Dive C. Avoidance of apoptosis as a mechanism of drug resistance. J. Intern. Med. Suppl., 740, 139, 1997.
6. In: Bauernfeind J.C. (Ed.). "Carotenoids as Colorants and Vitamin A Precursors: Technical and Nutritional Applications." Academic Press, New York, 1981.
7. Hill G.E. Energetic constraints on expression of carotenoid-based plumage coloration. J. Avian Biol., 31, 559, 2000.
8. Krinsky N.I. The antioxidant and biological properties of the carotenoids. Ann. NY Acad. Sci., 854, 443, 1998.
9. Johnson I.T. Antioxidants and anticarcinogens. Eur. J. Cancer Prev., 7 (Suppl. 2) S55, 1998.
10. Spitz D.R., Sim J.E., Ridnour L.A., Galoforo S.S., Lee Y.J. Glucose deprivation-induced oxidative stress in human tumor cells. A fundamental defect in metabolism? Ann. N.Y. Acad. Sci., 899, 349, 2000.
11. Kuhn R., Grundmann H. Synthese von descrocetin. Chem. Ber., 70, 1318, 1937.
12. Klein G., Dombos L., Gothoskar B. Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus. Int. J. Cancer, 10, 44, 1972.
13. Cleary M.L., Smith S.D., Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell, 47, 19, 1986.
14. Gallagher R., Collins S., Trujillo J., et al. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood, 54, 713, 1979.
15. Minowada J., Onuma T., Moore G.E. Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J. Natl. Cancer Inst., 49, 891, 1972.
16. Biedler J.L., Roffler-Tarlov S., Schachner M., Freedman L.S. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res., 38, 3751, 1978.
17. Mosmann T. Rapid colorimetric assay for cellular growth and survival. Application to proliferation and cytotoxicity assays. J. Immunol. Meth., 65, 55, 1983.